US2019038741A1PendingUtilityA1

Mixed allergen compositions and methods for using the same

Assignee: UNIV LELAND STANFORD JUNIORPriority: Feb 20, 2015Filed: May 25, 2018Published: Feb 7, 2019
Est. expiryFeb 20, 2035(~8.6 yrs left)· nominal 20-yr term from priority
Inventors:Kari C. Nadeau
A61P 37/08A61P 37/02A61P 43/00A61P 29/00A61P 1/00A61K 2035/115A61K 2039/57A61K 2039/55A61K 47/44A61K 31/593A61K 2039/70A23V 2002/00A61K 35/60A61K 47/46A61K 2039/54A61K 35/747A61K 45/06A61K 2039/542A61K 2039/575A23L 33/10A61K 47/10A61K 2039/572A61K 39/35A61K 2300/00A61K 39/36
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Mixed allergen compositions of two or more different allergens are provided. In some instances, the mixed allergen compositions include: a nut allergen; an animal allergen; and at least one of: a non-nut plant allergen; a biotic agent; and a vitamin. Also provided are methods of administering the mixed allergen compositions to a subject. The mixed allergen compositions find use in a variety of applications, including health maintenance, immune balance, gut balance, immune support, health improvement and therapeutic applications.

Claims

exact text as granted — not AI-modified
1 . A mixed allergen composition comprising:
 peanut complete allergen; and   at least one animal allergen selected from the group consisting of shrimp complete allergen, cod complete allergen and salmon complete allergen, wherein the peanut complete allergen and at least one animal allergen are at about equal parts by protein mass.   
     
     
         2 . The mixed allergen composition of  claim 1 , wherein the animal allergen is selected from the group consisting of shrimp complete allergen and cod complete allergen, and the shrimp complete allergen, cod complete allergen and the peanut complete allergen are at about equal parts by protein mass. 
     
     
         3 . The mixed allergen composition of  claim 1 , further comprising an allergen selected from the group consisting of an almond allergen, a walnut allergen, a cashew allergen, a hazelnut allergen, a pecan allergen and a pistachio allergen. 
     
     
         4 . The mixed allergen composition of  claim 1 , further comprising a wheat allergen. 
     
     
         5 . The mixed allergen composition of  claim 1 , further comprising an egg allergen. 
     
     
         6 . The mixed allergen composition of  claim 1 , further comprising a crab allergen. 
     
     
         7 . The mixed allergen composition of  claim 1 , further comprising an allergen selected from the group consisting of a sesame allergen and an oat allergen. 
     
     
         8 . The mixed allergen composition of  claim 1 , further comprising a soy allergen. 
     
     
         9 . The mixed allergen composition of  claim 1 , further comprising a milk allergen. 
     
     
         10 . (canceled) 
     
     
         11 . The mixed allergen composition of  claim 1 , further comprising a physiologically acceptable delivery vehicle. 
     
     
         12 . A food product comprising the unit formulation of a mixed allergen composition of  claim 21 . 
     
     
         13 . A method of treating a peanut allergy in a human subject in need thereof, the method comprising administering the unit formulation composition of  claim 19  to the subject. 
     
     
         14 .- 18 . (canceled) 
     
     
         19 . A unit formulation composition for oral administration comprising:
 0.5 mg to 5 g of a mixed allergen composition, by protein mass, wherein the mixed allergen composition comprises:   peanut complete allergen; a nut allergen selected from the group consisting of walnut complete allergen, cashew complete allergen, hazelnut complete allergen and combinations thereof; a soy allergen; and an animal allergen selected from the group consisting of shrimp complete allergen, cod complete allergen, salmon complete allergen and combinations thereof;   about 5 percent to about 95 percent, based on the total unit formulation composition, of a pharmaceutically acceptable carrier.   
     
     
         20 . The unit formulation composition for oral administration of  claim 19 , wherein the mixed allergen composition comprises, by total mass, about 15 mg to about 5000 mg of each allergen. 
     
     
         21 . A unit formulation of a mixed allergen composition comprising: about 15 mg to about 5000 mg cashew;
 about 15 mg to about 5000 mg walnut;   about 15 mg to about 5000 mg peanut;   about 15 mg to about 5000 mg hazelnut;   about 15 mg to about 5000 mg soy;   about 15 mg to about 5000 mg white and/or pink fish; and   about 15 mg to about 5000 mg weight hen's egg.   
     
     
         22 . A unit formulation composition for oral administration comprising the mixed allergen composition of  claim 21  and about 5 percent to about 95 percent, based on the weight of the total unit formulation composition, of a pharmaceutically acceptable carrier. 
     
     
         23 . A unit formulation of a mixed allergen composition comprising:
 about 1 mg to about 15000 mg cashew;   about 1 mg to about 15000 mg walnut;   about 1 mg to about 15000 mg peanut;   about 1 mg to about 15000 mg hazelnut;   about 1 mg to about 15000 mg soy;   about 1 mg to about 15000 mg white and/or pink fish; and   about 1 mg to about 15000 mg weight hen's egg; and   about 5 to about 95 percent, based on the weight of the total unit formulation composition, of a pharmaceutically acceptable carrier.

Join the waitlist — get patent alerts

Track US2019038741A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.